Drug company experts advised staff to withhold data about SSRI use in children
Canadian Medical Association JournalPublished 2 March 2004Open access
Wayne Kondro
Citations79
SJR quartileQ1
SJR score0.92
SNIP1.00
Generate an AI Snapshot to get a quick, structured summary of this paper.
Study Snapshot
ObjectiveStudy objective
MethodsResearch methodology
PopulationPopulation studied
Sample sizeSample sizes
OutcomesStudy outcomes here
ResultsStudy results comes here
LimitationsResearch study limitations comes here
A concise AI-generated summary of the paper will appear here once you click Generate AI Snapshot.
TL;DR
An internal document advised staff at the international drug giant GlaxoSmithKline to withhold clinical trial findings in 1998 that indicated the antidepressant paroxetine had no beneficial effect in treating adolescents.
Abstract
An internal document advised staff at the international drug giant GlaxoSmithKline (GSK) to withhold clinical trial findings in 1998 that indicated the antidepressant paroxetine (Paxil in North America and Seroxat in the UK) had no beneficial effect in treating adolescents. ![Figure][1]
Keywords
Psychology